Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 133

Similar articles for PubMed (Select 19234280)


MRI and PET/CT for triaging stage IB clinically operable cervical cancer to appropriate therapy: decision analysis to assess patient outcomes.

Pandharipande PV, Choy G, del Carmen MG, Gazelle GS, Russell AH, Lee SI.

AJR Am J Roentgenol. 2009 Mar;192(3):802-14. doi: 10.2214/AJR.08.1224. Erratum in: AJR Am J Roentgenol. 2009 May;192(5):1167.


Value of PET-CT in avoiding multimodality therapy in operable cervical cancer.

Goyal BK, Singh H, Kapur K, Duggal BS, Jacob MJ.

Int J Gynecol Cancer. 2010 Aug;20(6):1041-5. doi: 10.1111/IGC.0b013e3181dcadeb.


Role of imaging in pretreatment evaluation of early invasive cervical cancer: results of the intergroup study American College of Radiology Imaging Network 6651-Gynecologic Oncology Group 183.

Hricak H, Gatsonis C, Chi DS, Amendola MA, Brandt K, Schwartz LH, Koelliker S, Siegelman ES, Brown JJ, McGhee RB Jr, Iyer R, Vitellas KM, Snyder B, Long HJ 3rd, Fiorica JV, Mitchell DG; American College of Radiology Imaging Network 6651; Gynecologic Oncology Group 183.

J Clin Oncol. 2005 Dec 20;23(36):9329-37.


Detection of hematogenous bone metastasis in cervical cancer: 18F-fluorodeoxyglucose-positron emission tomography versus computed tomography and magnetic resonance imaging.

Liu FY, Yen TC, Chen MY, Lai CH, Chang TC, Chou HH, Hong JH, Chen YR, Ng KK.

Cancer. 2009 Dec 1;115(23):5470-80. doi: 10.1002/cncr.24599.


Comparative benefits and limitations of 18F-FDG PET and CT-MRI in documented or suspected recurrent cervical cancer.

Yen TC, Lai CH, Ma SY, Huang KG, Huang HJ, Hong JH, Hsueh S, Lin WJ, Ng KK, Chang TC.

Eur J Nucl Med Mol Imaging. 2006 Dec;33(12):1399-407. Epub 2006 Jul 18.


Pretreatment staging of cervical cancer: is imaging better than palpation?: Role of CT and MRI in preoperative staging of cervical cancer: single institution results for 255 patients.

Hancke K, Heilmann V, Straka P, Kreienberg R, Kurzeder C.

Ann Surg Oncol. 2008 Oct;15(10):2856-61. doi: 10.1245/s10434-008-0088-7. Epub 2008 Aug 12.


Positron emission tomography (PET) and magnetic resonance imaging (MRI) for the assessment of axillary lymph node metastases in early breast cancer: systematic review and economic evaluation.

Cooper KL, Meng Y, Harnan S, Ward SE, Fitzgerald P, Papaioannou D, Wyld L, Ingram C, Wilkinson ID, Lorenz E.

Health Technol Assess. 2011 Jan;15(4):iii-iv, 1-134. doi: 10.3310/hta15040. Review.


Patterns of failure and prognostic factor analyses in locally advanced cervical cancer patients staged by positron emission tomography and treated with curative intent.

Narayan K, Fisher RJ, Bernshaw D, Shakher R, Hicks RJ.

Int J Gynecol Cancer. 2009 Jul;19(5):912-8. doi: 10.1111/IGC.0b013e3181a58d3f.


Do clinical characteristics and metabolic markers detected on positron emission tomography/computerized tomography associate with persistent disease in patients with in-operable cervical cancer?

Akkas BE, Demirel BB, Dizman A, Vural GU.

Ann Nucl Med. 2013 Oct;27(8):756-63. doi: 10.1007/s12149-013-0745-1. Epub 2013 Jun 21.


Imaging in cervical cancer.

Follen M, Levenback CF, Iyer RB, Grigsby PW, Boss EA, Delpassand ES, Fornage BD, Fishman EK.

Cancer. 2003 Nov 1;98(9 Suppl):2028-38. Review.


The usefulness of MRI and PET imaging for the detection of parametrial involvement and lymph node metastasis in patients with cervical cancer.

Park W, Park YJ, Huh SJ, Kim BG, Bae DS, Lee J, Kim BH, Choi JY, Ahn YC, Lim DH.

Jpn J Clin Oncol. 2005 May;35(5):260-4. Epub 2005 May 10.


Restaging of recurrent cervical carcinoma with dual-phase [18F]fluoro-2-deoxy-D-glucose positron emission tomography.

Lai CH, Huang KG, See LC, Yen TC, Tsai CS, Chang TC, Chou HH, Ng KK, Hsueh S, Hong JH.

Cancer. 2004 Feb 1;100(3):544-52.


The correlation of preoperative CT, MR imaging, and clinical staging (FIGO) with histopathology findings in primary cervical carcinoma.

Ozsarlak O, Tjalma W, Schepens E, Corthouts B, Op de Beeck B, Van Marck E, Parizel PM, De Schepper AM.

Eur Radiol. 2003 Oct;13(10):2338-45. Epub 2003 Jun 12.


High-resolution whole-body magnetic resonance image tumor staging with the use of parallel imaging versus dual-modality positron emission tomography-computed tomography: experience on a 32-channel system.

Schmidt GP, Baur-Melnyk A, Herzog P, Schmid R, Tiling R, Schmidt M, Reiser MF, Schoenberg SO.

Invest Radiol. 2005 Dec;40(12):743-53.


Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment?

Ferrandina G, Petrillo M, Restaino G, Rufini V, Macchia G, Carbone A, Zannoni GF, Lucidi A, D'Angelo G, Scambia G.

Cancer. 2012 Jan 15;118(2):392-403. doi: 10.1002/cncr.26317. Epub 2011 Jun 30.


Role of magnetic resonance imaging and positron emission tomography/computed tomography in preoperative lymph node detection of uterine cervical cancer.

Chung HH, Kang KW, Cho JY, Kim JW, Park NH, Song YS, Kim SH, Chung JK, Kang SB.

Am J Obstet Gynecol. 2010 Aug;203(2):156.e1-5. doi: 10.1016/j.ajog.2010.02.041. Epub 2010 May 1.


A prospective diagnostic accuracy study of 18F-fluorodeoxyglucose positron emission tomography/computed tomography, multidetector row computed tomography, and magnetic resonance imaging in primary diagnosis and staging of pancreatic cancer.

Kauhanen SP, Komar G, Seppänen MP, Dean KI, Minn HR, Kajander SA, Rinta-Kiikka I, Alanen K, Borra RJ, Puolakkainen PA, Nuutila P, Ovaska JT.

Ann Surg. 2009 Dec;250(6):957-63. doi: 10.1097/SLA.0b013e3181b2fafa.


Additional value of MR/PET fusion compared with PET/CT in the detection of lymph node metastases in cervical cancer patients.

Kim SK, Choi HJ, Park SY, Lee HY, Seo SS, Yoo CW, Jung DC, Kang S, Cho KS.

Eur J Cancer. 2009 Aug;45(12):2103-9. doi: 10.1016/j.ejca.2009.04.006. Epub 2009 May 4.

Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk